EA200800971A1 - Фармацевтические композиции модулятора 5-нтрецепторов серотонина, полезные в лечении связанных с ними нарушений - Google Patents
Фармацевтические композиции модулятора 5-нтрецепторов серотонина, полезные в лечении связанных с ними нарушенийInfo
- Publication number
- EA200800971A1 EA200800971A1 EA200800971A EA200800971A EA200800971A1 EA 200800971 A1 EA200800971 A1 EA 200800971A1 EA 200800971 A EA200800971 A EA 200800971A EA 200800971 A EA200800971 A EA 200800971A EA 200800971 A1 EA200800971 A1 EA 200800971A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- symptoms
- anxiety
- psychosis
- treatment
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Настоящее изобретение относится к определенным фармацевтическим композициям модулятора 5-HTрецепторов серотонина и способам приготовления соответствующей фармацевтической композиции. Такие фармацевтические композиции полезны в лечении агрегации тромбоцитов, болезни коронарных артерий, инфаркта миокарда, преходящего ишемического нарушения мозгового кровообращения, стенокардии, инсульта, фибрилляции предсердий, в снижении риска образования тромбов, в лечении астмы или ее симптомов, тревожного состояния или симптомов, расстройств поведения, лекарственно индуцированного психоза, эксцитативного психоза, синдрома Тоуретта, маниакального расстройства, органического или NOS-психоза, психического расстройства, психоза, острой шизофрении, хронической шизофрении, NOS-шизофрении и связанных с этим расстройств, нарушений сна, диабет-ассоциированных расстройств, прогрессивной мультифокальной лейкоэнцефалопатии и подобного.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72178305P | 2005-09-29 | 2005-09-29 | |
PCT/US2006/038267 WO2007041409A1 (en) | 2005-09-29 | 2006-09-28 | Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200800971A1 true EA200800971A1 (ru) | 2008-08-29 |
Family
ID=37686009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200800971A EA200800971A1 (ru) | 2005-09-29 | 2006-09-28 | Фармацевтические композиции модулятора 5-нтрецепторов серотонина, полезные в лечении связанных с ними нарушений |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090053306A1 (ru) |
EP (1) | EP1928430A1 (ru) |
JP (1) | JP2009510115A (ru) |
KR (1) | KR20080055963A (ru) |
CN (1) | CN101272771A (ru) |
AU (1) | AU2006299656A1 (ru) |
BR (1) | BRPI0616791A2 (ru) |
CA (1) | CA2621152A1 (ru) |
EA (1) | EA200800971A1 (ru) |
IL (1) | IL190031A0 (ru) |
WO (1) | WO2007041409A1 (ru) |
ZA (1) | ZA200802608B (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1558582B1 (en) * | 2003-07-22 | 2005-12-21 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
ATE548353T1 (de) * | 2004-03-23 | 2012-03-15 | Arena Pharm Inc | Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon. |
TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
NZ581134A (en) * | 2007-04-13 | 2011-04-29 | Southern Res Institue | Use of anti-angiogenic agents and methods of use, in particular bithionol for inhibiting or reducing angiogenesis |
US9567327B2 (en) | 2007-08-15 | 2017-02-14 | Arena Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
US9034911B2 (en) | 2008-10-28 | 2015-05-19 | Arena Pharmaceuticals, Inc. | Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
DE112011103185T5 (de) | 2010-09-24 | 2013-07-18 | Fujimi Incorporated | Polierzusammensetzung und Spülzusammensetzung |
US10022263B2 (en) | 2011-07-14 | 2018-07-17 | Cook Medical Technologies Llc | Sling-based treatment of obstructive sleep apnea |
US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
ES2741560T3 (es) | 2012-03-30 | 2020-02-11 | Micelle Biopharma Inc | Composiciones de ésteres de ácidos grasos omega-3 |
US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
US10314736B2 (en) | 2012-10-16 | 2019-06-11 | Cook Medical Technologies Llc | Method and apparatus for treating obstructive sleep apnea (OSA) |
US9867733B2 (en) | 2013-08-01 | 2018-01-16 | Cook Medical Technologies Llc | Tissue adjustment implant |
AU2014306232B2 (en) | 2013-08-05 | 2018-12-06 | Cook Medical Technologies Llc | Medical devices having a releasable tubular member and methods of using the same |
EP2898920B1 (en) | 2014-01-24 | 2018-06-06 | Cook Medical Technologies LLC | Articulating balloon catheter |
US9974563B2 (en) | 2014-05-28 | 2018-05-22 | Cook Medical Technologies Llc | Medical devices having a releasable member and methods of using the same |
US9913661B2 (en) | 2014-08-04 | 2018-03-13 | Cook Medical Technologies Llc | Medical devices having a releasable tubular member and methods of using the same |
KR20180022792A (ko) | 2015-06-12 | 2018-03-06 | 엑소반트 사이언시즈 게엠베하 | 렘 수면 행동 장애의 예방 및 치료에 유용한 디아릴 및 아릴헤테로아릴 우레아 유도체 |
CN108472285A (zh) | 2015-07-15 | 2018-08-31 | 阿速万科学有限责任公司 | 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物 |
AU2018294247A1 (en) | 2017-06-29 | 2020-01-23 | Cook Biotech Incorporated | Implantable medical devices for tissue repositioning |
CN114259567A (zh) * | 2021-12-29 | 2022-04-01 | 中山大学 | 一种基于bcsⅲ类药物制剂的个性化给药方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1558582B1 (en) * | 2003-07-22 | 2005-12-21 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
US20080200530A1 (en) * | 2005-01-19 | 2008-08-21 | Unett David J | Diaryl and Arylheteroaryl Urea Derivatives as Modulators of 5-Ht2a Serotonin Receptor Useful for the Prophylaxis or Treatment of Progressive Multifocal Leukoencephalopathy |
-
2006
- 2006-09-28 KR KR1020087010166A patent/KR20080055963A/ko not_active Application Discontinuation
- 2006-09-28 EA EA200800971A patent/EA200800971A1/ru unknown
- 2006-09-28 US US11/992,806 patent/US20090053306A1/en not_active Abandoned
- 2006-09-28 AU AU2006299656A patent/AU2006299656A1/en not_active Abandoned
- 2006-09-28 CA CA002621152A patent/CA2621152A1/en not_active Abandoned
- 2006-09-28 JP JP2008533725A patent/JP2009510115A/ja not_active Withdrawn
- 2006-09-28 CN CNA2006800357258A patent/CN101272771A/zh active Pending
- 2006-09-28 BR BRPI0616791-8A patent/BRPI0616791A2/pt not_active Application Discontinuation
- 2006-09-28 EP EP06815932A patent/EP1928430A1/en not_active Withdrawn
- 2006-09-28 WO PCT/US2006/038267 patent/WO2007041409A1/en active Application Filing
-
2008
- 2008-03-09 IL IL190031A patent/IL190031A0/en unknown
- 2008-03-20 ZA ZA200802608A patent/ZA200802608B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0616791A2 (pt) | 2011-07-05 |
JP2009510115A (ja) | 2009-03-12 |
US20090053306A1 (en) | 2009-02-26 |
ZA200802608B (en) | 2009-03-25 |
WO2007041409A1 (en) | 2007-04-12 |
IL190031A0 (en) | 2008-08-07 |
EP1928430A1 (en) | 2008-06-11 |
CA2621152A1 (en) | 2007-04-12 |
CN101272771A (zh) | 2008-09-24 |
KR20080055963A (ko) | 2008-06-19 |
AU2006299656A1 (en) | 2007-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800971A1 (ru) | Фармацевтические композиции модулятора 5-нтрецепторов серотонина, полезные в лечении связанных с ними нарушений | |
EA200701101A1 (ru) | Производные 3-фенилпиразола в качестве модуляторов 5-htсеротонинового рецептора, полезные для лечения расстройств, связанных с этим рецептором | |
WO2007120600A3 (en) | 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
WO2007136680A3 (en) | 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
WO2006060762A3 (en) | Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
WO2007136875A3 (en) | Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
WO2008054748A3 (en) | Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
JO2954B1 (en) | Pirazol derivatives used as serotonin 5-Ht2a receptor controllers useful in the treatment of disorders related to these receptors | |
ECSP066269A (es) | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina útiles para la profilaxis y tratamiento de desórdenes relacionados con el mismo | |
WO2003062206A3 (en) | Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto | |
WO2010062323A3 (en) | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto | |
GT200600083A (es) | Derivados de oxiindol | |
EA200900623A1 (ru) | Бициклические соединения и их применение в качестве противодиабетических средств | |
NO20072348L (no) | Thienopyridinone sammensetninger og fremgangsmate for behandling | |
EA200801302A1 (ru) | Композиции и способы лечения нарушений цнс | |
ATE484501T1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
JP2010077101A (ja) | 腎線維症の治療剤又は予防剤 | |
GEP20104961B (en) | 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto | |
TH104739B (th) | อนุพันธ์ของพิแรโซลเป็นมอดูเลเตอร์ของ5ht2a เซอโรโทนิน รีเซปเตอร์ ที่มีประโยชน์สำหรับการบำบัดความผิดปกติที่เกี่ยวข้องกับมัน | |
TH124660B (th) | อนุพันธ์ 3-เฟนิล-ไพราโซลที่เป็นสารปรับปรุงการออกฤทธิ์ของตัวตอบรับซีโรโทนิน ชนิด 5-ht2a ซึ่งนำไปใช้ประโยชน์ต่อการรักษาอาการผิดปกติที่เกี่ยวข้องกับสารนั้น | |
DOP2005000235A (es) | Derivados de 3-fenil- pirazol como moduladores del receptor 5-ht2a de la serotonina utiles para el tretamiento de trastornos relacionados con este | |
TH86939B (th) | อนุพันธ์ไดแอริลและแอริลเฮเทโรแอริลยูเรียเป็นมอดูเลเตอร์ของ 5-ht2a เซอโรโทนินรีเซปเตอร์ที่มีประโยชน์สำหรับการป้องกันและการบำบัดความผิดปกติที่เกี่ยวกับมัน | |
TH104739A (th) | อนุพันธ์ของพิแรโซลเป็นมอดูเลเตอร์ของ 5ht2a เซอโรโทนิน รีเซปเตอร์ ที่มีประโยชน์สำหรับการบำบัดความผิดปกติที่เกี่ยวข้องกับมัน | |
TH124660A (th) | อนุพันธ์ 3-เฟนิล-ไพราโซล ที่เป็นสารปรับปรุงการออกฤทธิ์ของตัวตอบรับซีโรโทนินชนิด 5-ht2a ซึ่งนำไปใช้ประโยชน์ต่อการรักษาอาการผิดปกติที่เกี่ยวข้องกับสารนั้น | |
WO2010012811A3 (en) | Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |